Skip to main navigation Skip to search Skip to main content

Phase 3 randomised double blind study of dabrafenib (GSK2118436) in combination with trametinib (GSK1120212) versus placebo in adjuvant treatment of high-risk BRAF V600

Project: Research

Project Details

StatusFinished
Effective start/end date15/12/12 → 16/08/14

Clinical Trial Phase

  • Phase III (a & b)